Home/Filings/4/0001209191-05-041743
4//SEC Filing

ALTA BIOPHARMA PARTNERS II LP 4

Accession 0001209191-05-041743

CIK 0001118361other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 7:31 PM ET

Size

17.5 KB

Accession

0001209191-05-041743

Insider Transaction Report

Form 4
Period: 2005-08-08
Transactions
  • Other

    Common Stock

    2005-08-0817,74124,499 total(indirect: See footnote)
  • Other

    Common Stock

    2005-08-08482,259665,976 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2005-08-08482,259665,976 total(indirect: See footnote)
  • Other

    Common Stock

    2005-08-0817,74124,499 total(indirect: See footnote)
MARDUEL ALIX
Director
Transactions
  • Other

    Common Stock

    2005-08-0817,74124,499 total(indirect: See footnote)
  • Other

    Common Stock

    2005-08-08482,259665,976 total(indirect: See footnote)
DELEAGE JEAN
Director10% Owner
Transactions
  • Other

    Common Stock

    2005-08-08482,259665,976 total(indirect: See footnote)
  • Other

    Common Stock

    2005-08-0817,74124,499 total(indirect: See footnote)
ALTA PARTNERS II INC
Director10% Owner
Transactions
  • Other

    Common Stock

    2005-08-0817,74124,499 total(indirect: See footnote)
  • Other

    Common Stock

    2005-08-08482,259665,976 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2005-08-0817,74124,499 total(indirect: See footnote)
  • Other

    Common Stock

    2005-08-08482,259665,976 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2005-08-0817,74124,499 total(indirect: See footnote)
  • Other

    Common Stock

    2005-08-08482,259665,976 total(indirect: See footnote)
Footnotes (4)
  • [F1]n/a
  • [F2]Alta BioPharma Partners II, L.P. ("ABPII") distributed 482,259 shares to its general & limited partners based on their respective capital interests in ABPII in accordance with the Partnership Agreement without receipt of additional consideration from such partners.
  • [F3]Alta Partners II, Inc. ("APII") provides investment advisory services to several venture capital funds including, Alta BioPharma Partners II, L.P. ("ABPII") & Alta Embarcadero BioPharma Partners II, LLC ("AEP"). As a result of the Stock Distribution on 8/8/2005, ABPII now beneficially owns 665,976 shares and AEPII now owns 24,499 shares. The respective general partners and managing members of ABPII and AEBPII exercise sole voting and investment power with respect to the shares owned by such funds. Certain principals of APII are managing directors of Alta BioPharma Managment II, LLC (which is the general partner of ABPII) & managers of AEBPII (respectively) As managing directors and managers of such funds, they may be deemed to share voting and investment powers for the shares held by the foregoing funds. The principals of APII disclaim benefical ownership of all such shares held by the foregoing funds, except to the extent of their proportionate pecuniary interests therein.
  • [F4]Alta Embarcadero BioPharma Partners II, LLC ("AEPII") distributed 17,741 shares to its members based on their respective captial interests in AEPII in accordance with the Operating Agreement without receipt of additional consideration from such partners.

Issuer

RENOVIS INC

CIK 0001118361

Entity typeother

Related Parties

1
  • filerCIK 0001163156

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 7:31 PM ET
Size
17.5 KB